Peer Reviewed
Feature Article Respiratory medicine
Bronchiectasis: an often misdiagnosed condition
Abstract
Bronchiectasis affects many patients with established lung disease as well as most patients with cystic fibrosis. It is often not diagnosed in non-CF patients, and seeking and confirming the diagnosis in these patients allows the provision of disease-appropriate treatment, with major potential benefit.
Key Points
- Bronchiectasis frequently mimics common diseases such as COPD, asthma and chronic cough.
- Confirming a diagnosis of bronchiectasis enables the provision of disease-appropriate treatments and cessation of inappropriate treatments.
- Airway clearance and mucoactive therapies are key to improved outcomes, reduced exacerbations and improved quality of life.
- Treatment with antibiotics is important for eradication of bacteria from the airways, exacerbation management and long-term suppression of microbial colonists in the airways. It can be complex, given the multiple organisms possibly present.
- A diagnosis and management plan created in co-operation with respiratory physicians and respiratory physiotherapists can help simplify and improve management.
Get full access
Buy this article
Single article purchases are temporarily unavailable due to site maintenance.
If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.
Thank you for your patience and understanding.
Already a subscriber? Login here.